Accuvein Versus Standard Care for Intravenous Cannulation Procedure in Children
NCT ID: NCT03427723
Last Updated: 2018-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
300 participants
INTERVENTIONAL
2018-01-31
2020-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The cannulation is usually set up by the observation and touching of the veins by the nurse. However, this technique is often insufficient in young children and especially infants because they have a higher thickness adipose tissue. Their veins are of small caliber, hardly visible and palpable which increases the probability of a failure of the insertion of the catheter at the first attempt.
In the literature, different techniques are mentioned to promote the visualization of veins and thus the insertion of cannulation. The AccuVein®400 (AV400) system uses an infrared laser beam to project the image of superficial veins to the skin. In adults, AV400 has been shown to improve the success rate of insertion cannulation when venous capital is precarious. The question now arises as to whether this tool could be of interest to children who are particularly difficult to assist cannulation, especially the youngest of them.
Investigator hypothesize that AV400 could bring a benefit to the placement of cannulation, in the child with a venous capital difficult to catheterize and thus increase the success of the cannulation at the first attempt.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparison of the First Attempt Success Rate of Cannulation Between the Accuvein Apparatus and Standard Technique
NCT03462745
Evaluation of Accuvein in Adult Patients
NCT01020461
A Comparison of the Success Rate Of Cannulation Between The Accuvein Apparatus And Standard Technique
NCT01042613
AccuVein AV400 Device Versus Ultrasound-guided Cannulation of the Great Saphenous Vein at the Ankle in Infants
NCT04164862
Evaluation of a Touchless Vein Scanner for Venepuncture and Cannulation in Pediatric Patients
NCT01434537
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The DIVA score will be carried out by the nurse who takes care of the child thanks to the dedicated form. If the child has an Emla® patch, this score will be achieved after removing the patch. The nurse that will achieve the score will be the same that will pose the intravenous cannulation. Children with an assessment score \<4 will not be included in the study but will still be counted.
The nurse must perform the randomization by inquiring about the randomization week: standard method or AV400 method.
The information will be made to the parents and the information form given. The parents' consent regarding the care of their child will be collected by the same nurse.
The means of prevention of pain and distraction will be set up in box with the nurse and / or the auxiliary childcare and the parents. Peripheral intravenous cannulation will be performed by the nurse in collaboration with the auxiliary childcare.
Caregivers and parents will evaluate the care. The documents concerning the practical realization of the study will be grouped together and made available in each service in dedicated bins.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard care
visualization and palpation
Standard care
The intervention comes down to the randomization of the standard treatment versus Accuvein for peripheral intravenous cannulation
Accuvein
system uses an infrared laser beam to project the image of superficial veins to the skin
Accuvein®400
The intervention comes down to the randomization of the standard treatment versus Accuvein for peripheral intravenous cannulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Accuvein®400
The intervention comes down to the randomization of the standard treatment versus Accuvein for peripheral intravenous cannulation
Standard care
The intervention comes down to the randomization of the standard treatment versus Accuvein for peripheral intravenous cannulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Represented by a person having parental authority,
* Parents or holder of parental authority capable of giving their consent to the study.
Exclusion Criteria
* Care practiced by a student nurse or pediatric nurse
* Refusal of the child or the holder of parental authority.
1 Day
3 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Etienne MERLIN
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Clermont-Ferrand
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A02975-49
Identifier Type: OTHER
Identifier Source: secondary_id
CHU-374
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.